{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:56:24Z","timestamp":1740171384781,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report the case of a 22-year-old woman presenting with an acute onset of dizziness, gait dysbalance and blurred vision. Magnetic resonance imaging included 3 Tesla and 7 Tesla imaging and revealed a T2-hyperintense, T1-hypointense, non-contrast-enhancing lesion strictly confined to the white matter affecting the right optic radiation. An extensive ophthalmologic examination yielded mild quadrantanopia but no signs of optic neuropathy. The lesion was biopsied. The neuropathological evaluation revealed a demyelinating lesion with marked tissue vacuolization and granular myelin disintegration accompanied by mild T cell infiltration and a notable absence of myelin uptake by macrophages. Oligodendrocytes were strikingly enlarged, displaying oncocytic characteristics and showed cytoplasmic accumulation of mitochondria, which had mildly abnormal morphology on electron microscopy. The diagnosis of multiple sclerosis was excluded. Harding's disease, a variant of Leber's hereditary optic neuropathy, was then suspected. However, neither PCR for relevant mutations nor whole exome sequencing yielded known pathogenetic mutations in the patient's genome. We present a pattern of demyelinating tissue injury of unknown etiology with an oncocytic change of oligodendrocytes and a lack of adequate phagocytic response by macrophages, which to the best of our knowledge, has not been described before.<\/jats:p>","DOI":"10.1186\/s40478-022-01462-0","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T08:03:13Z","timestamp":1667894593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5160-5208","authenticated-orcid":false,"given":"Simon","family":"Hametner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Silvaieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majda","family":"Thurnher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assunta","family":"Dal-Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ponleitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Zebenholzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthold","family":"Pemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Trattnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"R\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Lassmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes A.","family":"Hainfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Bsteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"1462_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00401-011-0857-4","volume":"122","author":"Z Ahmed","year":"2011","unstructured":"Ahmed Z, Doherty KM, Silveira-Moriyama L, Bandopadhyay R, Lashley T, Mamais A, Hondhamuni G, Wray S, Newcombe J, O\u2019Sullivan SS et al (2011) Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies. Acta Neuropathol 122:415\u2013428. https:\/\/doi.org\/10.1007\/s00401-011-0857-4","journal-title":"Acta Neuropathol"},{"key":"1462_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/79944","volume":"26","author":"C Alexander","year":"2000","unstructured":"Alexander C, Votruba M, Pesch UEA, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo-Kottler B, Auburger G et al (2000) OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26:211\u2013215. https:\/\/doi.org\/10.1038\/79944","journal-title":"Nat Genet"},{"key":"1462_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1468-1331.2004.00822.x","volume":"11","author":"A Bourahoui","year":"2004","unstructured":"Bourahoui A, De Seze J, Guttierez R, Onraed B, Hennache B, Ferriby D, Stojkovic T, Vermersch P (2004) CSF isoelectrofocusing in a large cohort of MS and other neurological diseases. Eur J Neurol 11:525\u2013529. https:\/\/doi.org\/10.1111\/j.1468-1331.2004.00822.x","journal-title":"Eur J Neurol"},{"key":"1462_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10072-022-06057-0","volume":"43","author":"S Chen","year":"2022","unstructured":"Chen S, Zou JL, He S, Li W, Zhang JW, Li SJ (2022) Adult-onset autosomal dominant leukodystrophy and neuronal intranuclear inclusion disease: lessons from two new Chinese families. Neurol Sci 43:1\u20139. https:\/\/doi.org\/10.1007\/s10072-022-06057-0","journal-title":"Neurol Sci"},{"key":"1462_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","volume":"26","author":"C Delettre","year":"2000","unstructured":"Delettre C, Lenaers G, Griffoin J-M, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E et al (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26:207\u2013210. https:\/\/doi.org\/10.1038\/79936","journal-title":"Nat Genet"},{"key":"1462_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11255-019-02330-y","volume":"52","author":"Y Ding","year":"2020","unstructured":"Ding Y, Zou Q, Jin Y, Zhou J, Wang H (2020) Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease. Int Urol Nephrol 52:155\u2013159. https:\/\/doi.org\/10.1007\/s11255-019-02330-y","journal-title":"Int Urol Nephrol"},{"key":"1462_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/archneurol.2010.219","volume":"67","author":"A Echaniz-Laguna","year":"2010","unstructured":"Echaniz-Laguna A, Chassagne M, de Seze J, Mohr M, Clerc-Renaud P, Tranchant C, Mousson de Camaret B (2010) POLG1 variations presenting as multiple sclerosis. Arch Neurol 67:1140\u20131143. https:\/\/doi.org\/10.1001\/archneurol.2010.219","journal-title":"Arch Neurol"},{"key":"1462_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00401-019-02122-9","volume":"139","author":"I Ferrer","year":"2020","unstructured":"Ferrer I, Andres-Benito P, Zelaya MV, Aguirre MEE, Carmona M, Ausin K, Lachen-Montes M, Fernandez-Irigoyen J, Santamaria E, Del Rio JA (2020) Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy. Acta Neuropathol 139:735\u2013771. https:\/\/doi.org\/10.1007\/s00401-019-02122-9","journal-title":"Acta Neuropathol"},{"issue":"Pt 4","key":"1462_CR9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/brain\/115.4.979","volume":"115","author":"AE Harding","year":"1992","unstructured":"Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D, McDonald WI, Compston DA (1992) Occurrence of a multiple sclerosis-like illness in women who have a Leber\u2019s hereditary optic neuropathy mitochondrial DNA mutation. Brain 115(Pt 4):979\u2013989. https:\/\/doi.org\/10.1093\/brain\/115.4.979","journal-title":"Brain"},{"key":"1462_CR10","first-page":"443","volume":"50","author":"N Howell","year":"1992","unstructured":"Howell N, McCullough D, Bodis-Wollner I (1992) Molecular genetic analysis of a sporadic case of Leber hereditary optic neuropathy. Am J Hum Genet 50:443\u2013446","journal-title":"Am J Hum Genet"},{"key":"1462_CR11","first-page":"1147","volume":"48","author":"K Huoponen","year":"1991","unstructured":"Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus ML (1991) A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 48:1147\u20131153","journal-title":"Am J Hum Genet"},{"key":"1462_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/0022-510x(95)00287-c","volume":"135","author":"PH Jansen","year":"1996","unstructured":"Jansen PH, van der Knaap MS, de Coo IF (1996) Leber\u2019s hereditary optic neuropathy with the 11 778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical, MRI and MRS findings. J Neurol Sci 135:176\u2013180. https:\/\/doi.org\/10.1016\/0022-510x(95)00287-c","journal-title":"J Neurol Sci"},{"key":"1462_CR13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/0006-291x(92)90479-5","volume":"187","author":"DR Johns","year":"1992","unstructured":"Johns DR, Neufeld MJ, Park RD (1992) An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun 187:1551\u20131557. https:\/\/doi.org\/10.1016\/0006-291x(92)90479-5","journal-title":"Biochem Biophys Res Commun"},{"key":"1462_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41431-018-0235-y","volume":"27","author":"N Jurkute","year":"2019","unstructured":"Jurkute N, Majander A, Bowman R, Votruba M, Abbs S, Acheson J, Lenaers G, Amati-Bonneau P, Moosajee M, Arno G et al (2019) Clinical utility gene card for: inherited optic neuropathies including next-generation sequencing-based approaches. Eur J Hum Genet 27:494\u2013502. https:\/\/doi.org\/10.1038\/s41431-018-0235-y","journal-title":"Eur J Hum Genet"},{"key":"1462_CR15","first-page":"1","volume":"164","author":"P Kjer","year":"1959","unstructured":"Kjer P (1959) Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Suppl 164:1\u2013147","journal-title":"Acta Ophthalmol Suppl"},{"key":"1462_CR16","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1001\/archopht.1979.01020020248013","volume":"97","author":"LB Kline","year":"1979","unstructured":"Kline LB, Glaser JS (1979) Dominant optic atrophy. The clinical profile. Arch Ophthalmol 97:1680\u20131686. https:\/\/doi.org\/10.1001\/archopht.1979.01020020248013","journal-title":"Arch Ophthalmol"},{"key":"1462_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrneurol.2017.175","volume":"14","author":"W Kohler","year":"2018","unstructured":"Kohler W, Curiel J, Vanderver A (2018) Adulthood leukodystrophies. Nat Rev Neurol 14:94\u2013105. https:\/\/doi.org\/10.1038\/nrneurol.2017.175","journal-title":"Nat Rev Neurol"},{"key":"1462_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/brain\/awh310","volume":"128","author":"GG Kovacs","year":"2005","unstructured":"Kovacs GG, Hoftberger R, Majtenyi K, Horvath R, Barsi P, Komoly S, Lassmann H, Budka H, Jakab G (2005) Neuropathology of white matter disease in Leber\u2019s hereditary optic neuropathy. Brain 128:35\u201341. https:\/\/doi.org\/10.1093\/brain\/awh310","journal-title":"Brain"},{"key":"1462_CR19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s0140-6736(88)91632-7","volume":"1","author":"P Lestienne","year":"1988","unstructured":"Lestienne P, Ponsot G (1988) Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1:885. https:\/\/doi.org\/10.1016\/s0140-6736(88)91632-7","journal-title":"Lancet"},{"key":"1462_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::aid-ana3>3.0.co;2-q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717. https:\/\/doi.org\/10.1002\/1531-8249(200006)47:6%3c707::aid-ana3%3e3.0.co;2-q","journal-title":"Ann Neurol"},{"key":"1462_CR21","first-page":"481","volume":"59","author":"DA Mackey","year":"1996","unstructured":"Mackey DA, Oostra RJ, Rosenberg T, Nikoskelainen E, Bronte-Stewart J, Poulton J, Harding AE, Govan G, Bolhuis PA, Norby S (1996) Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 59:481\u2013485","journal-title":"Am J Hum Genet"},{"key":"1462_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1212\/wnl.50.2.417","volume":"50","author":"C Macmillan","year":"1998","unstructured":"Macmillan C, Kirkham T, Fu K, Allison V, Andermann E, Chitayat D, Fortier D, Gans M, Hare H, Quercia N et al (1998) Pedigree analysis of French Canadian families with T14484C Leber\u2019s hereditary optic neuropathy. Neurology 50:417\u2013422. https:\/\/doi.org\/10.1212\/wnl.50.2.417","journal-title":"Neurology"},{"key":"1462_CR23","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/brain\/awn105","volume":"131","author":"D Mahad","year":"2008","unstructured":"Mahad D, Ziabreva I, Lassmann H, Turnbull D (2008) Mitochondrial defects in acute multiple sclerosis lesions. Brain 131:1722\u20131735. https:\/\/doi.org\/10.1093\/brain\/awn105","journal-title":"Brain"},{"key":"1462_CR24","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.humpath.2013.02.014","volume":"44","author":"G Marucci","year":"2013","unstructured":"Marucci G, Maresca A, Caporali L, Farnedi A, Betts CM, Morandi L, de Biase D, Cerasoli S, Foschini MP, Bonora E et al (2013) Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy number. Hum Pathol 44:1867\u20131876. https:\/\/doi.org\/10.1016\/j.humpath.2013.02.014","journal-title":"Hum Pathol"},{"key":"1462_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/jnnp-2014-308186","volume":"86","author":"L Matthews","year":"2015","unstructured":"Matthews L, Enzinger C, Fazekas F, Rovira A, Ciccarelli O, Dotti MT, Filippi M, Frederiksen JL, Giorgio A, Kuker W et al (2015) MRI in Leber\u2019s hereditary optic neuropathy: the relationship to multiple sclerosis. J Neurol Neurosurg Psych 86:537\u2013542. https:\/\/doi.org\/10.1136\/jnnp-2014-308186","journal-title":"J Neurol Neurosurg Psych"},{"key":"1462_CR26","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1016\/j.ajpath.2014.07.015","volume":"184","author":"J Muller-Hocker","year":"2014","unstructured":"Muller-Hocker J, Schafer S, Krebs S, Blum H, Zsurka G, Kunz WS, Prokisch H, Seibel P, Jung A (2014) Oxyphil cell metaplasia in the parathyroids is characterized by somatic mitochondrial DNA mutations in NADH dehydrogenase genes and cytochrome c oxidase activity-impairing genes. Am J Pathol 184:2922\u20132935. https:\/\/doi.org\/10.1016\/j.ajpath.2014.07.015","journal-title":"Am J Pathol"},{"key":"1462_CR27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/jclinpath-2015-203585","volume":"69","author":"KL Ng","year":"2016","unstructured":"Ng KL, Morais C, Bernard A, Saunders N, Samaratunga H, Gobe G, Wood S (2016) A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma. J Clin Pathol 69:661\u2013671. https:\/\/doi.org\/10.1136\/jclinpath-2015-203585","journal-title":"J Clin Pathol"},{"key":"1462_CR28","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1136\/jnnp-2020-325803","volume":"92","author":"M Nolan","year":"2021","unstructured":"Nolan M, Barbagallo P, Turner MR, Keogh MJ, Chinnery PF, Talbot K, Ansorge O (2021) Isolated homozygous R217X OPTN mutation causes knock-out of functional C-terminal optineurin domains and associated oligodendrogliopathy-dominant ALS-TDP. J Neurol Neurosurg Psychiatry 92:1022\u20131024. https:\/\/doi.org\/10.1136\/jnnp-2020-325803","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1462_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/jnen\/62.3.217","volume":"62","author":"A Oldfors","year":"2003","unstructured":"Oldfors A, Tulinius M (2003) Mitochondrial encephalomyopathies. J Neuropathol Exp Neurol 62:217\u2013227. https:\/\/doi.org\/10.1093\/jnen\/62.3.217","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 5","key":"1462_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/brain\/109.5.915","volume":"109","author":"RK Petty","year":"1986","unstructured":"Petty RK, Harding AE, Morgan-Hughes JA (1986) The clinical features of mitochondrial myopathy. Brain 109(Pt 5):915\u2013938. https:\/\/doi.org\/10.1093\/brain\/109.5.915","journal-title":"Brain"},{"key":"1462_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.06.014","volume":"262","author":"A Petzold","year":"2013","unstructured":"Petzold A (2013) Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J Neuroimmunol 262:1\u201310. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.06.014","journal-title":"J Neuroimmunol"},{"key":"1462_CR32","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1212\/01.wnl.0000437308.22603.43","volume":"81","author":"G Pfeffer","year":"2013","unstructured":"Pfeffer G, Burke A, Yu-Wai-Man P, Compston DA, Chinnery PF (2013) Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology 81:2073\u20132081. https:\/\/doi.org\/10.1212\/01.wnl.0000437308.22603.43","journal-title":"Neurology"},{"key":"1462_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.410390311","volume":"39","author":"S Rahman","year":"1996","unstructured":"Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, Christodoulou J, Thorburn DR (1996) Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39:343\u2013351. https:\/\/doi.org\/10.1002\/ana.410390311","journal-title":"Ann Neurol"},{"key":"1462_CR34","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1523\/JNEUROSCI.4077-15.2016","volume":"36","author":"MB Rone","year":"2016","unstructured":"Rone MB, Cui QL, Fang J, Wang LC, Zhang J, Khan D, Bedard M, Almazan G, Ludwin SK, Jones R et al (2016) Oligodendrogliopathy in multiple sclerosis: low glycolytic metabolic rate promotes oligodendrocyte survival. J Neurosci 36:4698\u20134707. https:\/\/doi.org\/10.1523\/JNEUROSCI.4077-15.2016","journal-title":"J Neurosci"},{"key":"1462_CR35","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3174\/ajnr.A7097","volume":"42","author":"SD Roosendaal","year":"2021","unstructured":"Roosendaal SD, van de Brug T, Alves C, Blaser S, Vanderver A, Wolf NI, van der Knaap MS (2021) Imaging patterns characterizing mitochondrial leukodystrophies. AJNR Am J Neuroradiol 42:1334\u20131340. https:\/\/doi.org\/10.3174\/ajnr.A7097","journal-title":"AJNR Am J Neuroradiol"},{"key":"1462_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4103\/aian.aian_952_21","volume":"25","author":"P Sarkar","year":"2022","unstructured":"Sarkar P, Mukherjee A, Sarkar S, Agrawal R, Dubey S, Pandit A (2022) Adult-onset dystonia with late-onset epilepsy in TUBB4A-related hypomyelinating leukodystrophy-a new intermediate phenotype. Ann Indian Acad Neurol 25:562\u2013565. https:\/\/doi.org\/10.4103\/aian.aian_952_21","journal-title":"Ann Indian Acad Neurol"},{"key":"1462_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138267","author":"SL Stenton","year":"2021","unstructured":"Stenton SL, Sheremet NL, Catarino CB, Andreeva NA, Assouline Z, Barboni P, Barel O, Berutti R, Bychkov I, Caporali L et al (2021) Impaired complex I repair causes recessive Leber\u2019s hereditary optic neuropathy. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI138267","journal-title":"J Clin Invest"},{"key":"1462_CR38","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2176\/nmc.32.911","volume":"32","author":"S Tsunoda","year":"1992","unstructured":"Tsunoda S, Sakaki T, Kubota T, Goda K, Nakamura M, Hashimoto H, Hoshida T, Morimoto T (1992) Anaplastic astrocytoma of an oncocytic type occurring in the cerebellar vermis in Pierre Robin syndrome\u2013case report. Neurol Med Chir (Tokyo) 32:911\u2013914. https:\/\/doi.org\/10.2176\/nmc.32.911","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1462_CR39","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.3201231","volume":"242","author":"DC Wallace","year":"1988","unstructured":"Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ 2nd, Nikoskelainen EK (1988) Mitochondrial DNA mutation associated with Leber\u2019s hereditary optic neuropathy. Science 242:1427\u20131430. https:\/\/doi.org\/10.1126\/science.3201231","journal-title":"Science"},{"key":"1462_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.05.019","author":"H Wei","year":"2022","unstructured":"Wei H, Moffett JR, Amanat M, Fatemi A, Tsukamoto T, Namboodiri AM, Slusher BS (2022) The pathogenesis of, and pharmacological treatment for Canavan disease. Drug Discov Today. https:\/\/doi.org\/10.1016\/j.drudis.2022.05.019","journal-title":"Drug Discov Today"},{"key":"1462_CR41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21465","volume":"64","author":"GK Wenning","year":"2008","unstructured":"Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG (2008) Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol 64:239\u2013246. https:\/\/doi.org\/10.1002\/ana.21465","journal-title":"Ann Neurol"},{"key":"1462_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-012-0965-9","volume":"124","author":"A Woehrer","year":"2012","unstructured":"Woehrer A, Laszlo L, Finsterer J, Stollberger C, Furtner J, Rinner W, Molnar K, Budka H, Kovacs GG (2012) Novel crystalloid oligodendrogliopathy in hereditary spastic paraplegia. Acta Neuropathol 124:583\u2013591. https:\/\/doi.org\/10.1007\/s00401-012-0965-9","journal-title":"Acta Neuropathol"},{"key":"1462_CR43","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/acn3.323","volume":"3","author":"P Yu-Wai-Man","year":"2016","unstructured":"Yu-Wai-Man P, Spyropoulos A, Duncan HJ, Guadagno JV, Chinnery PF (2016) A multiple sclerosis-like disorder in patients with OPA1 mutations. Ann Clin Transl Neurol 3:723\u2013729. https:\/\/doi.org\/10.1002\/acn3.323","journal-title":"Ann Clin Transl Neurol"},{"key":"1462_CR44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12031-013-0026-4","volume":"51","author":"A Zendedel","year":"2013","unstructured":"Zendedel A, Beyer C, Kipp M (2013) Cuprizone-induced demyelination as a tool to study remyelination and axonal protection. J Mol Neurosci 51:567\u2013572. https:\/\/doi.org\/10.1007\/s12031-013-0026-4","journal-title":"J Mol Neurosci"},{"key":"1462_CR45","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/glia.21052","volume":"58","author":"I Ziabreva","year":"2010","unstructured":"Ziabreva I, Campbell G, Rist J, Zambonin J, Rorbach J, Wydro MM, Lassmann H, Franklin RJ, Mahad D (2010) Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes. Glia 58:1827\u20131837. https:\/\/doi.org\/10.1002\/glia.21052","journal-title":"Glia"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01462-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01462-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01462-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T08:10:43Z","timestamp":1667895043000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01462-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01462-0","relation":{},"ISSN":["2051-5960"],"issn-type":[{"type":"electronic","value":"2051-5960"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the Medical University of Vienna approved the study (EK 2323\u20132019), and the patient gave her written consent to publication of this case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Simon Hametner has participated in meetings sponsored by or received speaker honoraria from Biogen and Sanofi-Genzyme. He has received an unrestricted research grant from Merck. Sara Silvaieh: has nothing to disclose. Majda Thurnher: has nothing to disclose. Assunta Dal-Bianco: ADB\u2019s position as junior group leader for Translational Morphology in Neuroscience is supported by a research grant from Biogen. She has participated in meetings sponsored by, received speaker honoraria or travel funding from Biogen, Celgene (BMS), Merck, Novartis, Roche and Sanofi; and has received an unrestricted grant from Merck GmbH, an affiliate of Merck KGaA. Hakan Cetin: has nothing to disclose. Markus Ponleitner: has participated in meetings sponsored by, received speaker or consulting honoraria or travel funding from Amicus, Merck, Novartis and Sanofi-Genzyme. Karin Zebenholzer: has nothing to disclose. Berthold Pemp: has received honoraria for consulting Chiesi and GenSight, and received honoraria for speaking from Chiesi and Santen. Siegfried Trattnig: has nothing to disclose. Karl R\u00f6ssler: has nothing to disclose. Thomas Berger: has participated in meetings sponsored by and received honoraria (lectures, advisory boards, consultations) from pharmaceutical companies marketing treatments for MS: Allergan, Bayer, Biogen, Biologix, Bionorica, BMS\/Celgene, Eisai, Genesis, GSK, GW\/Jazz, Horizon, Janssen-Cilag, MedDay, Merck, Novartis, Octapharma, Roche, Sandoz, Sanofi-Genzyme, Teva and UCB. His institution has received financial support in the past 12\u00a0months by unrestricted research grants (Biogen, Bayer, BMS\/Celgene, Merck, Novartis, Roche, Sanofi-Genzyme, Teva and for participation in clinical trials in multiple sclerosis sponsored by Alexion, Bayer, Biogen, Merck, Novartis, Octapharma, Roche, Sanofi-Genzyme, Teva. Hans Lassmann: has nothing to disclose. Johannes A. Hainfellner: has nothing to disclose. Gabriel Bsteh: has participated in meetings sponsored by, received speaker honoraria or travel funding from Biogen, Celgene\/BMS, Lilly, Merck, Novartis, Roche, Sanofi-Genzyme and Teva, and received honoraria for consulting Biogen, Celgene\/BMS, Novartis, Roche, Sanofi-Genzyme and Teva. He has received unrestricted research grants from Celgene\/BMS and Novartis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}